$201 Million is the total value of Essex Woodlands Management, Inc.'s 8 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PSDV | Buy | EYEPOINT | $75,018,000 | -5.3% | 41,909,219 | +0.0% | 37.35% | +18.4% |
| AXGN | AXOGEN INC | $57,699,000 | +3.1% | 2,739,751 | 0.0% | 28.73% | +28.9% | |
| RVNC | REVANCE THERAPEUTICS INC | $52,671,000 | -42.6% | 3,342,047 | 0.0% | 26.22% | -28.2% | |
| MNOV | MEDICINOVA INC | $9,691,000 | -33.7% | 1,170,370 | 0.0% | 4.82% | -17.1% | |
| CORI | Buy | CORIUM | $3,488,000 | +3.7% | 0 | +100.0% | 1.74% | +29.7% |
| ELGX | ENDOLOGIX INC | $1,293,000 | -75.9% | 1,257,468 | 0.0% | 0.64% | -69.8% | |
| CBIO | CATALYST | $640,000 | +2.4% | 78,622 | 0.0% | 0.32% | +28.1% | |
| ACUR | ACURA PHARMACEUTICALS INC | $352,000 | +63.7% | 1,956,397 | 0.0% | 0.18% | +103.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDICINOVA INC | 42 | Q3 2023 | 6.5% |
| REVANCE THERAPEUTICS INC | 39 | Q3 2023 | 44.6% |
| AXOGEN INC | 26 | Q4 2021 | 43.3% |
| ENDOLOGIX INC | 24 | Q1 2019 | 22.5% |
| ABIOMED INC | 20 | Q1 2018 | 52.1% |
| CORIUM INTL INC | 20 | Q1 2019 | 23.5% |
| TELA BIO, INC. | 16 | Q3 2023 | 31.5% |
| VENUS CONCEPT, INC. | 16 | Q3 2023 | 21.3% |
| ACURA PHARMACEUTICALS INC | 15 | Q1 2019 | 1.4% |
| CATALYST BIOSCIENCES INC | 15 | Q1 2019 | 1.0% |
View Essex Woodlands Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Essex Woodlands Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.